V. Kalyuzhin

发表

Chronic heart failure: syndrome or disease?

V. L. Ostanko, N. Chasovskikh, A. T. Teplyakov, 2020 .

Advanced heart failure

M. A. Osipova, V. Usov, E. Grakova, 2021, Bulletin of Siberian Medicine.

Diuretic resistance in patients with chronic heart failure: mechanisms, prevention, and treatment

V. L. Ostanko, N. Garganeeva, V. Usov, 2022, Bulletin of Siberian Medicine.

Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma

N. I. Tarasov, E. Grakova, O. Ogurkova, 2018, Bulletin of Siberian Medicine.

Correct diagnostic conclusion in patients with chronic heart failure: a reality or a pipe dream?

V. L. Ostanko, A. T. Teplyakov, I. D. Bespalova, 2020, Bulletin of Siberian Medicine.

Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction

K. Kopeva, A. Teplyakov, T. Suslova, 2022, Bulletin of Siberian Medicine.

SAFETY OF STATIN ADMINISTRATION IN PATIENTS WITH SEVERE DISEASES ASSOCIATED WITH METABOLIC SYNDROME

I. D. Bespalova, V. Kalyuzhin, Yu. A. Medyantsev, 2012 .

Predictive factors of cardiovascular changes depending on the type and intensity of physical activity in professional athletes

N. Garganeeva, V. Kalyuzhin, E. Kalyuzhina, 2021, Russian Journal of Cardiology.

Promising directions in the treatment of chronic heart failure: improving old or developing new ones?

O. A. Pavlenko, N. Garganeeva, V. Usov, 2022, Bulletin of Siberian Medicine.

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases

K. Kopeva, S. Shilov, A. Popova, 2023, Bulletin of Siberian Medicine.

Diastolic heart failure: boundaries of term application

O. A. Pavlenko, N. Garganeeva, V. Usov, 2023, Bulletin of Siberian Medicine.

The contingency of parameters of human encephalograms and Schumann resonance electromagnetic fields revealed in monitoring studies

S. V. Pobachenko, A. S. Borodin, A. G. Kolesnik, 2006 .

Asymptomatic hyperuricemia as a component of metabolic syndrome

V. Kalyuzhin, A. Yu, 2012 .

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction

A. Mochula, K. Zavadovsky, A. Maltseva, 2023, Bulletin of Siberian Medicine.

[Myocardial and Arterial Stiffness Important Determinant of NT-ProBNP at Development of Heart Failure in Survivors of Myocardial Infarction].

R. Karpov, T. Suslova, A. T. Teplyakov, 2016, Kardiologiia.

Subpopulation composition and prooxidant activity of visceral adipose tissue cells in patients with metabolic syndrome

A. V. Teteneva, I. D. Bespalova, I. A. Osikhov, 2022, The Siberian Journal of Clinical and Experimental Medicine.

The role of endosarcomeric cytoskeleton proteins in the mechanisms of left ventricular diastolic dysfunction: focus on titin

V. Usov, E. Grakova, K. Kopeva, 2023, Bulletin of Siberian Medicine.

Adipokine imbalance and its role in the pathogenesis of novel coronavirus infection

E. Koroleva, I. D. Bespalova, Yu. I. Koshchavtseva, 2024, Bulletin of Siberian Medicine.

New draft classification of chronic heart failure of the Russian Society of Cardiology: are there any obvious advantages over the current ones?

V. L. Ostanko, E. Grakova, K. Kopeva, 2024, Bulletin of Siberian Medicine.